Alle Studien
Einschreibung auf EinladungBEOBACHTEND

International Registry of Congenital Portosystemic Shunt (IRCPSS)

The International Registry of Congenital Portosystemic Shunt (IRCPSS) is collecting health information from people globally who have a rare condition called Congenital Portosystemic Shunt (CPSS). In CPSS, blood from the gut doesn't go through the liver properly, which can lead to various health problems. Because the condition is rare and its effects vary greatly, doctors want to understand it better. This registry aims to centralise detailed health records and biological data. By bringing together experts from different fields, the study hopes to learn more about how common CPSS is, how it develops over time, why some people face more severe issues, and the underlying causes. This knowledge is crucial for providing better care and support to individuals with CPSS.

Auf einen Blick

Status
Einschreibung auf Einladung
Sponsor
Prof. Valérie Mc Lin
Einschreibeziel
500
Starten
26 Apr 2018
Geschätzte Fertigstellung
31 Dez 2028

Worum geht es in dieser Studie?

This study is called the International Registry of Congenital Portosystemic Shunt (IRCPSS). It focuses on a rare condition known as Congenital Portosystemic Shunt, often shortened to CPSS. In simple terms, CPSS means that some blood from your digestive system, instead of flowing fully through your liver to be filtered, bypasses it. Think of it like a shortcut in your bloodstream. When this happens, substances that would normally be processed by the liver can build up in the body, potentially causing various health problems.

Because CPSS is uncommon and can affect people very differently, it's currently hard for doctors to predict who will develop serious complications. Some people might have mild symptoms, while others could experience more significant health issues. This registry aims to collect detailed health information, including medical history and biological samples, from people with CPSS all around the world.

A large team of medical experts from various fields is working together on this project. By gathering and analysing this information globally, they hope to get a clearer picture of how many people have CPSS, how it progresses over time, what causes the different health problems, and why some individuals are more at risk. This deeper understanding is vital to improve diagnosis, treatment, and overall care for everyone with CPSS.

Wichtige Erkenntnisse

  • CPSS is a rare condition where blood bypasses the liver.
  • The study aims to understand CPSS better through a global registry.
  • Participation involves sharing medical data, not new treatments.
  • Experts from around the world are collaborating.
  • The goal is to improve future care for people with CPSS.

Wer könnte berechtigt sein?

To be included in this study, you must have a diagnosis of Congenital Portosystemic Shunt (CPSS). This means you were born with this specific condition where blood bypasses the liver.

You would not be able to join if your shunt (the bypassed blood vessel) developed later in life due to another medical problem, and you don't have evidence of being born with a shunt.

Könnte diese Studie für Sie geeignet sein?

Beantworten Sie diese kurzen Fragen, um zu sehen, ob Sie möglicherweise berechtigt sind. Dies ist nur ein Leitfaden – das Forschungsteam trifft die endgültige Entscheidung.

  1. I have been diagnosed with Congenital Portosystemic Shunt (CPSS).
  2. I was born with the shunt, rather than it developing later in life.
  3. I am open to sharing my existing medical information for research.
  4. I understand that this is an observational study, not a treatment trial.
Beantworten Sie jede Frage, um Ihr Ergebnis zu sehen.

Was beinhaltet die Teilnahme?

This study involves gathering your existing medical information and possibly some biological samples, though the detailed description doesn't specify new appointments or treatments as part of the registry itself. It's about collecting data to understand the condition better, rather than testing a new treatment. The purpose is to combine information from many people with CPSS globally to learn more about the condition. The total duration of your involvement would depend on how long your medical information is followed within the registry, but it does not require you to undergo any specific intervention or attend extra visits beyond your usual medical care.

Potenzielle Risiken und Vorteile

Participating in this registry involves sharing your health information, which is always handled with strict confidentiality. The main benefit is contributing to a greater understanding of CPSS, potentially leading to improved care and treatments for others in the future. While there are no direct personal medical benefits from joining an observational registry, the knowledge gained could ultimately help you or your loved ones. You are always free to withdraw your consent to participate at any time without affecting your medical care.

Standorte (26)

  • Yale University School of Medicine
    Verifizierte Postleitzahl
    New Haven, Vereinigte Staaten
  • Lurie Children's Hospital
    Verifizierte Postleitzahl
    Chicago, Vereinigte Staaten
  • Königliches Kinderkrankenhaus Melbourne
    Verifizierte Postleitzahl
    Parkville, Australien
  • Universitary Clinics Saint-Luc, UCL
    Verifizierte Postleitzahl
    Brüssel, Belgien
  • The Hospital for Sick Children
    Verifizierte Postleitzahl
    Toronto, Kanada
  • Beaujon University Hospital
    Verifizierte Postleitzahl
    Clichy, France
  • Hôpital Bicêtre-Hôpitaux Universitaires Paris-Sud- Assistance Publique Hôpitaux de Paris.
    Verifizierte Postleitzahl
    Le Kremlin-Bicêtre, France
  • Hôpital Necker
    Verifizierte Postleitzahl
    Paris, Frankreich
  • Medizinische Hochschule Hannover
    Verifizierte Postleitzahl
    Hannover, Deutschland
  • Haunersche Kinderklinik - LMU Munich
    Verifizierte Postleitzahl
    München, Deutschland
  • University of Tuebingen
    Verifizierte Postleitzahl
    Tübingen, Germany
  • First Department of Pediatrics, Semmelweis University
    Verifizierte Postleitzahl
    Budapest, Ungarn

Häufige Fragen

What is Congenital Portosystemic Shunt (CPSS)?

It's a rare condition where some blood from your gut doesn't pass through your liver as it should, but instead bypasses it. This can lead to various health issues.

Warum ist diese Studie wichtig?

Because CPSS is rare and complex, doctors need more information to understand how it affects people, why some get serious complications, and how best to care for them.

Will I receive any new treatment if I join?

No, this is a registry, meaning it collects information from existing medical records. It's not a study that tests new medications or treatments.

Wer führt diese Studie durch?

A group of medical experts from different fields around the world are working together to gather and understand the information.

Will my personal details be kept private?

Yes, all your personal health information will be handled with strict confidentiality and privacy guidelines.

Wie Sie mehr erfahren können

Sprechen Sie immer mit Ihrem Hausarzt oder Spezialisten, bevor Sie sich entscheiden, an einer Studie teilzunehmen.

Interessiert daran, teilzunehmen?

Registrieren Sie Ihr Interesse

Teilen Sie Ihre Details und das Forschungsteam für "International Registry of Congenital Portosystemic Shunt (IR… wird Sie kontaktieren, wenn Sie möglicherweise infrage kommen. Sprechen Sie immer mit Ihrem Hausarzt, bevor Sie zustimmen, teilzunehmen.

Diskussion

Community-Diskussion

Bereitgestellt von unserem Forum bei community.patient.info. Bitte seien Sie respektvoll — dies ist kein medizinischer Rat.